2019 | |
---|---|
Criterium: | Position: |
Overall Score: | 400-500 |
Total Project Funding per Partner: | 200-300 |
Total Number of Projects: | > 1000 |
Total number of projects: 1
As coordinator: 1
As participant: 0
Sole participant: 0
Coordinator / Participant Ratio: *
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 6.926.375 | 0 | 6.926.375 | 1 |
Institution: | Projects [No]: |
---|---|
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL | 1 |
Total number of partners: 1
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 1
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-05-01 | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | TRIC-TB | coordinator | 6.926.375 | 2 |